MedRx Co., Ltd (TSE:4586) announced a private placement of 30,000 series 20 warrants at a price of ¥57 each for gross proceeds of ¥1,710,000 and 19,000 series 21 warrants at a price of ¥41 per share for gross proceeds of ¥779,000 for aggregate gross proceeds of ¥2,489,000 and Series 2 Unsecured Bonds on May 18, 2021. The company will issue securities through third party allotment method to Macquarie Bank Limited, Investment Arm. The series 20 warrants at exercisable at a minimum price of ¥223 and series 21 Warrants for ¥330.